Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].

Zhonghua bing li xue za zhi = Chinese journal of pathology - 8 Feb 2024

Wang W N, Liu X T, Liang Y M

Abstract excerpt

Objective: To investigate the clinicopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors, and the diagnostic value of the cells in serous effusion. Methods: Eleven cases of SMARCA4-deficient tumor were collected from the Affiliated Hospital of Hebei University, China from January 2018 to July 2023, which were diagnosed using cell block of serous effusion. The clinical,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to Cell Nucleus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Mutation

Share to Nuclear Proteins

Share to Prognosis

Share to Transcription Factors

Source

Identifiers

PMID: 38281781
DOI: 10.3760/cma.j.cn112151-20230718-00012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].PMID 38281781Read ↗

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].Semantic proximity Read ↗

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.Semantic proximity Read ↗

[Clinicopathological analysis of SMARCA4-deficient tumors of digestive system origin].Semantic proximity Read ↗

Defining the first bona fide cell model for SMARCA4-deficient, undifferentiated tumor.Semantic proximity Read ↗

[Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].Semantic proximity Read ↗

Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.Semantic proximity Read ↗

Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors.Semantic proximity Read ↗

SMARCA4-deficient thoracic malignancies with small cell lung cancer-like features: A clinicopathological and molecular study of a heterogeneous group.Semantic proximity Read ↗

Establishment and characterization of TRI-LC21: a novel patient-derived cell line of SMARCA4-deficient undifferentiated thoracic tumor.Semantic proximity Read ↗

Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case SeriesSemantic proximity Read ↗

Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4- deficent thoracic tumorsSemantic proximity Read ↗

SMARCA4-deficient undifferentiated tumor presenting with fever and polyarthralgia: A case reportSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.